Creative use of the priority review voucher by public and not-for-profit actors delivers the first new FDA-approved treatment for river blindness in 20 years

Saved in:

Bibliographic Details
Published in:	PLoS Negl Trop Dis
Main Authors:	Olliaro, Piero L., Kuesel, Annette C., Halleux, Christine M., Sullivan, Mark, Reeder, John C.
Format:	Artigo
Language:	Inglês
Published:	Public Library of Science 2018
Subjects:	Viewpoints
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC6237288/ https://ncbi.nlm.nih.gov/pubmed/30439940 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0006837
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items